This is the authors' abstract. We don't add key points for this paper.
Surgical mesh is commonly used in hernia repair to reduce recurrence, but it is associated with a risk of postoperative wound infections, most often caused by Staphylococcus aureus. Cannabidiol (CBD) has shown antibacterial and anti-inflammatory effects in laboratory studies. This study assessed whether cannabidiol-impregnated mesh reduces infection rates compared with untreated mesh in an animal model. 60 rats were randomized into four groups: one received standard mesh without bacterial exposure, one received standard mesh with bacterial exposure, one received cannabidiol-treated mesh with bacterial exposure, and one received cannabidiol-treated mesh without bacterial exposure. After implantation, animals were monitored for 14 days, and infection was assessed through clinical signs, microbiological cultures, histology, and inflammatory markers. Rats with cannabidiol-treated mesh showed a reduced infection rate (40%) compared to the infection control group (80%) (p = 0.0604). Histological inflammation and bacterial load were also lower in the CBD group. Inflammatory markers were comparable between groups. The study found that CBD-impregnated mesh implants exhibited a lower incidence of bacterial infections compared to the control group. These findings suggest that CBD-impregnated hernia mesh implants may offer a protective effect against S. aureus-related wound infections, potentially improving postoperative outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hráček et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: